Key Sessions
Plenary Keynote Session: Navigating the Evolving Bioprocessing Landscape - Regulation, Innovation & Compliance
Jenny Ann Prange
Helping patients to regain control: From pre-clinical research to clinical
MUVON Therapeutics AG
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day One (13th May 2025) - CET/CEST (Cent Europe Summer, GMT+2)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Day One (13th May 2025) - CET/CEST (Cent Europe Summer, GMT+2)
search
Streams
Clear
Showing 1 of 1 Streams
Cell and Gene Therapy Manufacturing
09:00 - 09:05
Chairperson Opening Remarks: Cell and Gene Therapy Manufacturing
09:05 - 09:35
Helping patients to regain control: From pre-clinical research to clinical
- Jenny Ann Prange - Head of Production, CTO and Co-founder, MUVON Therapeutics AG
09:35 - 10:05
Why Transfection Complex Size Could Make or Break AAV Manufacturing
- Vincent Wiegmann - Senior Scientist, MeiraGTx
10:05 - 10:35
Seamless ATMP Production: Streamlining Manufacturing with Integrated Solutions
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
Showing 1 of 1 Streams
Cell and Gene Therapy Manufacturing
11:20 - 11:50
Real-Time Analytics to Empower ATMP Manufacturing from Development to Delivery
Unique challenges of scaling up CGT manufacturing and how real time analytics can be used to aid in scale up
Implementing PAT (Process Analytical Technology) and other real-time monitoring tools
- Using data to identify and address process deviations proactively
- Building a robust data infrastructure for ATMP manufacturing
Importance of tech transfer:
- How to approach this
- Best practices
11:50 - 12:20
Automation for Success: Boosting Efficiency, Quality & Safety for ATMPs
- Lior Raviv - Chief Technology Officer, Pluri Biotech Ltd
Showing 1 of 1 Streams
Cell and Gene Therapy Manufacturing
14:15 - 14:20
Chairperson Remarks: Cell and Gene Therapy Manufacturing
14:20 - 14:50
Transforming Spinal Cord Injury Treatment: NurExone's Groundbreaking Exosome-Based siRNA Therapy and Expanding Pipeline for Neuronal Regeneration
- Lior Shaltiel - CEO, NurExone Biologic
14:50 - 15:20
Navigating the Regulatory Landscape for Fast-Tracking ATMP Approvals
- Tiffany Rau, PhD - Adjunct Professor Biochemistry and Cell Biology, University College Cork, Ireland
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Clear